Founded in 1989, Sudeep Pharma Limited is a globally recognized manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients, serving a market spanning over 100 countries. The company’s extensive operations are supported by six manufacturing facilities with a combined capacity of 50,000 MT, producing a diverse range of over 200 mineral-based products—including calcium, iron, magnesium, zinc, potassium, and sodium—for clients in the pharmaceutical, food, and nutrition sectors. As of December 31, 2024, Sudeep Pharma employed a permanent workforce of 704 individuals.
Sudeep Pharma Limited’s Initial Public Offering (IPO) is scheduled to open on November 21, 2025, and close on November 25, 2025. Structured as a Book Built Issue, the IPO aims to raise approximately ₹895 crores. This comprises a fresh issue of ₹95.00 crores and an offer for sale of up to 1,34,90,726 equity shares, each with a face value of ₹1. The price band has been set between ₹563 and ₹593 per share.
The allotment is reserved as 35% for retail investors (QIB), 50% for Qualified Institutional Buyers, and 15% for High Net Worth Individuals (HNIs). The share allotment will be finalized on November 26, 2025, with the subsequent listing on both the BSE and NSE expected by November 28, 2025. Financially, the company has shown consistent growth, reporting a revenue increase to ₹511.33 crores in 2025 from ₹465.38 crores in 2024, alongside a rise in profit to ₹138.69 crores from ₹133.15 crores in the previous year.
Sudeep Pharma IPO Details
| IPO Date | November 21, 2025 to November 25, 2025 |
| Listing Date | [.] |
| Face Value | ₹1 per share |
| Issue Price Band | ₹563 to ₹593 per share |
| Lot Size | 25 Shares |
| Total Issue Size | Approx ₹895 Crores |
| Fresh Issue | Approx ₹95.00 Crores |
| Offer for Sale | Approx 1,34,90,726 Equity Shares |
| Issue Type | Book building IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 11,13,46,602 shares |
| Share Holding Post Issue | 11,29,48,626 shares |
Sudeep Pharma IPO Dates
The Initial Public Offering (IPO) for Sudeep Pharma is set to commence on November 21, 2025, and will conclude on November 25, 2025.
| IPO Open Date | Fri, Nov 21, 2025 |
| IPO Close Date | Tue, Nov 25, 2025 |
| Tentative Allotment | Wed, Nov 26, 2025 |
| Refunds | Thu, Nov 27, 2025 |
| Credit of Shares to Demat | Thu, Nov 27, 2025 |
| Tentative Listing Date | Fri, Nov 28, 2025 |
| UPI Mandate Confirmation Deadline | 5 PM on Tue, Nov 25, 2025 |
Sudeep Pharma IPO Market Lot
Sudeep Pharma IPO, the minimum market lot is set at 25 shares, requiring an application amount of ₹14,825. Retail investors have the option to apply for a maximum of 13 lots, which translates to 325 shares, amounting to a total investment of ₹1,92,725.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 25 | ₹14,825 |
| Retail Maximum | 13 | 325 | ₹1,92,725 |
| S-HNI Minimum | 14 | 350 | ₹2,07,550 |
| S-HNI Maximum | 67 | 1,675 | ₹9,93,275 |
| B-HNI Minimum | 68 | 1,700 | ₹10,08,100 |
